Results
2303
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2303 companies
Bicara Therapeutics
Market Cap: US$544.3m
A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.
BCAX
US$9.46
7D
-35.2%
1Y
n/a
Mind Medicine (MindMed)
Market Cap: US$539.5m
A clinical stage biopharmaceutical company, develops novel products to treat brain health disorders.
MNMD
US$7.15
7D
3.0%
1Y
-19.8%
Eton Pharmaceuticals
Market Cap: US$537.4m
A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
ETON
US$20.08
7D
-0.8%
1Y
442.7%
Enhabit
Market Cap: US$529.2m
Provides home health and hospice services in the United States.
EHAB
US$10.36
7D
-0.7%
1Y
14.5%
LifeMD
Market Cap: US$524.5m
Operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.
LFMD
US$11.47
7D
6.5%
1Y
45.0%
OrthoPediatrics
Market Cap: US$523.1m
A medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.
KIDS
US$20.44
7D
-6.5%
1Y
-37.0%
Upstream Bio
Market Cap: US$517.5m
A clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.
UPB
US$9.22
7D
3.2%
1Y
n/a
Axogen
Market Cap: US$514.6m
Develops and commercializes technologies for peripheral nerve regeneration and repair worldwide.
AXGN
US$10.96
7D
-3.8%
1Y
63.3%
Owens & Minor
Market Cap: US$504.9m
Operates as a healthcare solutions company worldwide.
OMI
US$6.52
7D
-5.1%
1Y
-62.5%
Community Health Systems
Market Cap: US$501.6m
Owns, leases, and operates general acute care hospitals in the United States.
CYH
US$3.77
7D
-4.6%
1Y
0.8%
Stoke Therapeutics
Market Cap: US$501.2m
An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.
STOK
US$9.43
7D
-0.5%
1Y
-31.5%
Talkspace
Market Cap: US$493.6m
Operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States.
TALK
US$2.96
7D
1.9%
1Y
10.9%
Maze Therapeutics
Market Cap: US$490.5m
A clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States.
MAZE
US$11.48
7D
9.1%
1Y
n/a
Relay Therapeutics
Market Cap: US$488.6m
Operates as a clinical-stage precision medicines company.
RLAY
US$2.95
7D
3.1%
1Y
-52.3%
Arvinas
Market Cap: US$488.3m
A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.
ARVN
US$7.29
7D
16.6%
1Y
-78.5%
Virtus Health
Market Cap: AU$705.2m
Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore.
VRT
AU$8.10
7D
3.7%
1Y
11.0%
Kura Oncology
Market Cap: US$485.7m
A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.
KURA
US$5.55
7D
-10.5%
1Y
-72.9%
EyePoint Pharmaceuticals
Market Cap: US$484.4m
Engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.
EYPT
US$7.04
7D
25.7%
1Y
-34.5%
Semler Scientific
Market Cap: US$483.9m
Provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States.
SMLR
US$41.32
7D
-8.0%
1Y
28.2%
Auna
Market Cap: US$483.8m
A healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia.
AUNA
US$6.47
7D
-5.4%
1Y
-22.2%
Definitive Healthcare
Market Cap: US$480.0m
Provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally.
DH
US$3.25
7D
3.5%
1Y
-38.7%
Botanix Pharmaceuticals
Market Cap: AU$745.1m
Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.
BOT
AU$0.38
7D
0%
1Y
31.0%
Capricor Therapeutics
Market Cap: US$479.0m
A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.
CAPR
US$10.65
7D
-4.2%
1Y
90.2%
SBC Medical Group Holdings
Market Cap: US$476.6m
Provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore.
SBC
US$4.50
7D
29.7%
1Y
-65.8%
Opthea
Market Cap: AU$738.8m
A clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States.
OPT
AU$0.60
7D
0%
1Y
9.1%
Tyra Biosciences
Market Cap: US$469.0m
A clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.
TYRA
US$8.99
7D
-7.9%
1Y
-43.6%
Verastem
Market Cap: US$468.2m
A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.
VSTM
US$7.61
7D
0%
1Y
90.3%
Theravance Biopharma
Market Cap: US$464.0m
A biopharmaceutical company, develops and commercializes of medicines in the United States.
TBPH
US$9.15
7D
-2.8%
1Y
10.4%
Allergy Therapeutics
Market Cap: UK£343.2m
A commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders.
AGY
UK£0.072
7D
2.9%
1Y
80.0%
Zevra Therapeutics
Market Cap: US$462.0m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$8.33
7D
-3.8%
1Y
81.3%
Cullinan Therapeutics
Market Cap: US$461.5m
A clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States.
CGEM
US$7.84
7D
-0.4%
1Y
-65.4%
Castle Biosciences
Market Cap: US$456.2m
A molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma, and mental health conditions.
CSTL
US$16.23
7D
1.3%
1Y
-33.8%
REGENXBIO
Market Cap: US$455.0m
A clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.
RGNX
US$8.54
7D
-11.4%
1Y
-39.5%
Sana Biotechnology
Market Cap: US$451.1m
A biotechnology company, focuses on utilizing engineered cells as medicines in the United States.
SANA
US$2.25
7D
14.8%
1Y
-71.0%
PYC Therapeutics
Market Cap: AU$699.9m
A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.
PYC
AU$1.20
7D
-1.6%
1Y
9.1%
Claritev
Market Cap: US$450.4m
Provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.
CTEV
US$26.66
7D
-7.4%
1Y
14.8%